KEWAUNEE SCIENTIFIC CP (KEQU) Fundamental Analysis & Valuation

NASDAQ:KEQUUS4928541048

Current stock price

34.53 USD
+0.43 (+1.26%)
Last:

This KEQU fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

6

1. KEQU Profitability Analysis

1.1 Basic Checks

  • In the past year KEQU was profitable.
  • KEQU had a positive operating cash flow in the past year.
  • In multiple years KEQU reported negative net income over the last 5 years.
  • In multiple years KEQU reported negative operating cash flow during the last 5 years.
KEQU Yearly Net Income VS EBIT VS OCF VS FCFKEQU Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5M -5M 10M 15M

1.2 Ratios

  • The Return On Assets of KEQU (6.21%) is better than 84.13% of its industry peers.
  • KEQU has a Return On Equity of 16.81%. This is amongst the best in the industry. KEQU outperforms 92.06% of its industry peers.
  • With an excellent Return On Invested Capital value of 10.67%, KEQU belongs to the best of the industry, outperforming 91.01% of the companies in the same industry.
  • KEQU had an Average Return On Invested Capital over the past 3 years of 9.90%. This is in line with the industry average of 9.31%.
  • The 3 year average ROIC (9.90%) for KEQU is below the current ROIC(10.67%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 6.21%
ROE 16.81%
ROIC 10.67%
ROA(3y)6.79%
ROA(5y)2.22%
ROE(3y)17.94%
ROE(5y)5.55%
ROIC(3y)9.9%
ROIC(5y)N/A
KEQU Yearly ROA, ROE, ROICKEQU Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 -10 20 30

1.3 Margins

  • KEQU has a better Profit Margin (4.11%) than 76.72% of its industry peers.
  • KEQU has a Operating Margin of 6.89%. This is in the better half of the industry: KEQU outperforms 73.02% of its industry peers.
  • The Gross Margin of KEQU (29.09%) is worse than 74.07% of its industry peers.
  • In the last couple of years the Gross Margin of KEQU has grown nicely.
Industry RankSector Rank
OM 6.89%
PM (TTM) 4.11%
GM 29.09%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y25.96%
GM growth 5Y12.54%
KEQU Yearly Profit, Operating, Gross MarginsKEQU Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 20

5

2. KEQU Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), KEQU is creating some value.
  • Compared to 1 year ago, KEQU has about the same amount of shares outstanding.
  • The number of shares outstanding for KEQU has been increased compared to 5 years ago.
  • The debt/assets ratio for KEQU is higher compared to a year ago.
KEQU Yearly Shares OutstandingKEQU Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500K 1M 1.5M 2M 2.5M
KEQU Yearly Total Debt VS Total AssetsKEQU Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M

2.2 Solvency

  • An Altman-Z score of 3.25 indicates that KEQU is not in any danger for bankruptcy at the moment.
  • The Altman-Z score of KEQU (3.25) is better than 70.37% of its industry peers.
  • The Debt to FCF ratio of KEQU is 12.32, which is on the high side as it means it would take KEQU, 12.32 years of fcf income to pay off all of its debts.
  • KEQU's Debt to FCF ratio of 12.32 is fine compared to the rest of the industry. KEQU outperforms 71.96% of its industry peers.
  • KEQU has a Debt/Equity ratio of 0.85. This is a neutral value indicating KEQU is somewhat dependend on debt financing.
  • KEQU's Debt to Equity ratio of 0.85 is on the low side compared to the rest of the industry. KEQU is outperformed by 71.96% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.85
Debt/FCF 12.32
Altman-Z 3.25
ROIC/WACC1.01
WACC10.53%
KEQU Yearly LT Debt VS Equity VS FCFKEQU Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20M 40M 60M

2.3 Liquidity

  • KEQU has a Current Ratio of 2.48. This indicates that KEQU is financially healthy and has no problem in meeting its short term obligations.
  • The Current ratio of KEQU (2.48) is comparable to the rest of the industry.
  • A Quick Ratio of 1.71 indicates that KEQU should not have too much problems paying its short term obligations.
  • With a Quick ratio value of 1.71, KEQU perfoms like the industry average, outperforming 46.03% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.48
Quick Ratio 1.71
KEQU Yearly Current Assets VS Current LiabilitesKEQU Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M

1

3. KEQU Growth Analysis

3.1 Past

  • KEQU shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -71.96%.
  • KEQU shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -18.78% yearly.
  • The Revenue has decreased by -7.27% in the past year.
  • Measured over the past years, KEQU shows a small growth in Revenue. The Revenue has been growing by 5.68% on average per year.
EPS 1Y (TTM)-71.96%
EPS 3Y-27.83%
EPS 5Y-18.78%
EPS Q2Q%-74.31%
Revenue 1Y (TTM)-7.27%
Revenue growth 3Y4.46%
Revenue growth 5Y5.68%
Sales Q2Q%3.32%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
KEQU Yearly Revenue VS EstimatesKEQU Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M
KEQU Yearly EPS VS EstimatesKEQU Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 0.5 1 1.5

5

4. KEQU Valuation Analysis

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 8.14, the valuation of KEQU can be described as reasonable.
  • Based on the Price/Earnings ratio, KEQU is valued cheaply inside the industry as 94.18% of the companies are valued more expensively.
  • When comparing the Price/Earnings ratio of KEQU to the average of the S&P500 Index (25.54), we can say KEQU is valued rather cheaply.
Industry RankSector Rank
PE 8.14
Fwd PE N/A
KEQU Price Earnings VS Forward Price EarningsKEQU Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, KEQU is valued cheaply inside the industry as 97.88% of the companies are valued more expensively.
  • Based on the Price/Free Cash Flow ratio, KEQU is valued cheaper than 88.89% of the companies in the same industry.
Industry RankSector Rank
P/FCF 19.35
EV/EBITDA 5.68
KEQU Per share dataKEQU EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60 80

4.3 Compensation for Growth

  • KEQU has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. KEQU Dividend Analysis

5.1 Amount

  • KEQU does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

KEQU Fundamentals: All Metrics, Ratios and Statistics

KEWAUNEE SCIENTIFIC CP

NASDAQ:KEQU (3/23/2026, 8:02:20 PM)

34.53

+0.43 (+1.26%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)03-11
Earnings (Next)06-23
Inst Owners41.72%
Inst Owner Change3.9%
Ins Owners15.69%
Ins Owner Change-3.95%
Market Cap99.10M
Revenue(TTM)146.60M
Net Income(TTM)11.74M
Analysts82.86
Price TargetN/A
Short Float %1.59%
Short Ratio5.61
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 8.14
Fwd PE N/A
P/S 0.35
P/FCF 19.35
P/OCF 11.43
P/B 1.42
P/tB 2.46
EV/EBITDA 5.68
EPS(TTM)4.24
EY12.28%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)1.78
FCFY5.17%
OCF(TTM)3.02
OCFY8.75%
SpS99.48
BVpS24.34
TBVpS14.04
PEG (NY)N/A
PEG (5Y)N/A
Graham Number48.19
Profitability
Industry RankSector Rank
ROA 6.21%
ROE 16.81%
ROCE 13.73%
ROIC 10.67%
ROICexc 11.69%
ROICexgc 15.07%
OM 6.89%
PM (TTM) 4.11%
GM 29.09%
FCFM 1.79%
ROA(3y)6.79%
ROA(5y)2.22%
ROE(3y)17.94%
ROE(5y)5.55%
ROIC(3y)9.9%
ROIC(5y)N/A
ROICexc(3y)12.02%
ROICexc(5y)N/A
ROICexgc(3y)13.16%
ROICexgc(5y)N/A
ROCE(3y)12.97%
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y25.96%
GM growth 5Y12.54%
F-Score4
Asset Turnover1.51
Health
Industry RankSector Rank
Debt/Equity 0.85
Debt/FCF 12.32
Debt/EBITDA 2.29
Cap/Depr 56.58%
Cap/Sales 1.24%
Interest Coverage 250
Cash Conversion 33.42%
Profit Quality 43.61%
Current Ratio 2.48
Quick Ratio 1.71
Altman-Z 3.25
F-Score4
WACC10.53%
ROIC/WACC1.01
Cap/Depr(3y)110.02%
Cap/Depr(5y)97.64%
Cap/Sales(3y)1.65%
Cap/Sales(5y)1.54%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-71.96%
EPS 3Y-27.83%
EPS 5Y-18.78%
EPS Q2Q%-74.31%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-7.27%
Revenue growth 3Y4.46%
Revenue growth 5Y5.68%
Sales Q2Q%3.32%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y20.12%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y1290.93%
FCF growth 3YN/A
FCF growth 5Y49.49%
OCF growth 1Y51.55%
OCF growth 3YN/A
OCF growth 5Y28.86%

KEWAUNEE SCIENTIFIC CP / KEQU Fundamental Analysis FAQ

What is the ChartMill fundamental rating of KEWAUNEE SCIENTIFIC CP (KEQU) stock?

ChartMill assigns a fundamental rating of 4 / 10 to KEQU.


What is the valuation status of KEWAUNEE SCIENTIFIC CP (KEQU) stock?

ChartMill assigns a valuation rating of 5 / 10 to KEWAUNEE SCIENTIFIC CP (KEQU). This can be considered as Fairly Valued.


How profitable is KEWAUNEE SCIENTIFIC CP (KEQU) stock?

KEWAUNEE SCIENTIFIC CP (KEQU) has a profitability rating of 6 / 10.


How financially healthy is KEWAUNEE SCIENTIFIC CP?

The financial health rating of KEWAUNEE SCIENTIFIC CP (KEQU) is 5 / 10.


Is the dividend of KEWAUNEE SCIENTIFIC CP sustainable?

The dividend rating of KEWAUNEE SCIENTIFIC CP (KEQU) is 0 / 10 and the dividend payout ratio is 0%.